{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:24:36Z","timestamp":1793111076736,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ncl.2013.04.004","type":"journal-article","created":{"date-parts":[[2013,10,25]],"date-time":"2013-10-25T22:30:44Z","timestamp":1382740244000},"page":"1009-1029","source":"Crossref","is-referenced-by-count":76,"title":["Muscular Dystrophies and Other Genetic Myopathies"],"prefix":"10.1016","volume":"31","author":[{"given":"Perry B.","family":"Shieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2013.04.004_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2013.04.004_bib2","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/BF00210802","article-title":"Segregation analysis of 1885 DMD families: significant departure from the expected proportion of sporadic cases","volume":"84","author":"Barbujani","year":"1990","journal-title":"Hum Genet"},{"key":"10.1016\/j.ncl.2013.04.004_bib3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0888-7543(88)90113-9","article-title":"An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus","volume":"2","author":"Monaco","year":"1988","journal-title":"Genomics"},{"key":"10.1016\/j.ncl.2013.04.004_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2013.04.004_bib5","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/WCO.0b013e32832fd487","article-title":"Emerging genetic therapies to treat Duchenne muscular dystrophy","volume":"22","author":"Nelson","year":"2009","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.ncl.2013.04.004_bib6","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/WCO.0b013e328357b0be","article-title":"Gene therapy for Duchenne muscular dystrophy","volume":"25","author":"Verhaart","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.ncl.2013.04.004_bib7","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1177\/0883073810371129","article-title":"Read-through strategies for suppression of nonsense mutations in Duchenne\/Becker muscular dystrophy: aminoglycosides and ataluren (PTC124)","volume":"25","author":"Finkel","year":"2010","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.ncl.2013.04.004_bib8","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(11)60756-3","article-title":"Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study","volume":"378","author":"Cirak","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2013.04.004_bib9","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1011367","article-title":"Systemic administration of PRO051 in Duchenne's muscular dystrophy","volume":"364","author":"Goemans","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2013.04.004_bib10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/WCO.0b013e328357f22d","article-title":"Facioscapulohumeral muscular dystrophy: consequences of chromatin relaxation","volume":"25","author":"van der Maarel","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.ncl.2013.04.004_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/ng1262","article-title":"Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy","volume":"35","author":"van Overveld","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.ncl.2013.04.004_bib12","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1189044","article-title":"A\u00a0unifying genetic model for facioscapulohumeral muscular dystrophy","volume":"329","author":"Lemmers","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ncl.2013.04.004_bib13","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1212\/WNL.0b013e3181f96175","article-title":"Clinical features of facioscapulohumeral muscular dystrophy 2","volume":"75","author":"de Greef","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2013.04.004_bib14","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ng.2454","article-title":"Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2","volume":"44","author":"Lemmers","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.ncl.2013.04.004_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11926-011-0178-6","article-title":"The muscular dystrophies: distinct pathogenic mechanisms invite novel therapeutic approaches","volume":"13","author":"Sahenk","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ncl.2013.04.004_bib16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.nmd.2006.06.008","article-title":"Severe phenotype in infantile facioscapulohumeral muscular dystrophy","volume":"16","author":"Klinge","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ncl.2013.04.004_bib17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ana.410430303","article-title":"Facioscapulohumeral Dystrophy: a distinct regional myopathy with a novel molefular pathogenesis","volume":"432","author":"Tawil","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2013.04.004_bib18","unstructured":"Orphanet Report Series\u2014Prevalence of rare diseases: Bibliographic data\u2014November 2012-Number 1. Available at: http:\/\/www.orpha.net\/consor\/cgi-bin\/Education.php?lng=EN."},{"key":"10.1016\/j.ncl.2013.04.004_bib19","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S1474-4422(12)70204-1","article-title":"The myotonic dystrophies: molecular, clinical, and therapeutic challenges","volume":"11","author":"Udd","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2013.04.004_bib20","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/WCO.0b013e3282ef6064","article-title":"Myotonic dystrophy: RNA-mediated muscle disease","volume":"20","author":"Wheeler","year":"2007","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.ncl.2013.04.004_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature11362","article-title":"Targeting nuclear RNA for in\u00a0vivo correction of myotonic dystrophy","volume":"488","author":"Wheeler","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ncl.2013.04.004_bib22","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/jnnp.2009.193938","article-title":"Diagnosis and management of the limb girdle muscular dystrophies","volume":"9","author":"Bushby","year":"2009","journal-title":"Pract Neurol"},{"key":"10.1016\/j.ncl.2013.04.004_bib23","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1007\/s00018-006-6247-8","article-title":"Emery\u2013Dreifuss muscular dystrophy at the nuclear envelope: 10 years on","volume":"63","author":"Ellis","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ncl.2013.04.004_bib24","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1093\/hmg\/ddm238","article-title":"Nesprin-1 and -2 are involved in the pathogenesis of Emery\u2013Dreifuss muscular dystrophy and are critical for nuclear envelope integrity","volume":"16","author":"Zhang","year":"2007","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.ncl.2013.04.004_bib25","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajhg.2009.07.015","article-title":"Mutations of the FHL1 gene cause Emery\u2013Dreifuss muscular dystrophy","volume":"85","author":"Gueneau","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ncl.2013.04.004_bib26","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/ana.22338","article-title":"TMEM43 mutations in Emery-Dreifuss muscular dystrophy-related myopathy","volume":"69","author":"Liang","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2013.04.004_bib27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.nmd.2011.10.003","article-title":"Distal myopathies \u2013 new genetic entities expand diagnostic challenge","volume":"22","author":"Udd","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ncl.2013.04.004_bib28","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/ana.23831","article-title":"Welander distal myopathy is caused by a mutation in the RNA-binding protein TIA1","volume":"73","author":"Hackman","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2013.04.004_bib29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.nmd.2010.12.007","article-title":"Myofibrillar myopathies","volume":"21","author":"Selcen","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ncl.2013.04.004_bib30","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/ng.1103","article-title":"Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy","volume":"44","author":"Sarparanta","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.ncl.2013.04.004_bib31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11910-009-0012-y","article-title":"Oculopharyngeal muscular dystrophy: a polyalanine myopathy","volume":"9","author":"Brais","year":"2009","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.ncl.2013.04.004_bib32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1212\/WNL.0b013e318207b043","article-title":"Oculopharyngodistal myopathy is a distinct entity: clinical and genetic features of 47 patients","volume":"76","author":"Durmus","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2013.04.004_bib33","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.spen.2011.10.006","article-title":"Centronuclear mypoathies","volume":"18","author":"Romero","year":"2011","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.ncl.2013.04.004_bib34","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1212\/WNL.0b013e3182a6ca62","article-title":"Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy","volume":"81","author":"Ceyhan","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2013.04.004_bib35","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.spen.2011.10.004","article-title":"Nemaline myopathies","volume":"18","author":"Wallgren-Pettersson","year":"2011","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.ncl.2013.04.004_bib36","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.spen.2011.10.005","article-title":"Core myopathies","volume":"18","author":"Jungbluth","year":"2011","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.ncl.2013.04.004_bib37","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.spen.2011.10.008","article-title":"Congenital fiber type disproportion","volume":"18","author":"Clarke","year":"2011","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.ncl.2013.04.004_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ana.23548","article-title":"The ever-expanding spectrum of congenital muscular dystrophies","volume":"72","author":"Mercuri","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2013.04.004_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.nmd.2011.10.009","article-title":"Current status of the congenital myasthenic syndromes","volume":"22","author":"Engel","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ncl.2013.04.004_bib40","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.nmd.2011.12.004","article-title":"186th ENMC international workshop: congenital myasthenic syndromes 24-26 June 2011, Naarden, The Netherlands","volume":"22","author":"Chaouch","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ncl.2013.04.004_bib41","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11910-010-0096-4","article-title":"A\u00a0diagnostic algorithm for metabolic myopathies","volume":"10","author":"Berardo","year":"2010","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.ncl.2013.04.004_bib42","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/WCO.0b013e32833cc97e","article-title":"Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis","volume":"23","author":"Raja Rayan","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.ncl.2013.04.004_bib43","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cell.2009.12.024","article-title":"Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis","volume":"140","author":"Ryan","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ncl.2013.04.004_bib44","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.spen.2006.06.004","article-title":"Autophagic vacuolar myopathy","volume":"13","author":"Nishino","year":"2006","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.ncl.2013.04.004_bib45","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature06639","article-title":"Autophagy fights disease through cellular self digestion","volume":"451","author":"Mizushima","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ncl.2013.04.004_bib46","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1212\/WNL.58.12.1773","article-title":"Clinicopathological features of genetically confirmed Danon disease","volume":"58","author":"Sugie","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2013.04.004_bib47","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-012-1073-6","article-title":"VMA21 deficiency prevents vacuolar ATPase assembly and cause autophagic vacuolar myopathy","volume":"125","author":"Ramachandran","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ncl.2013.04.004_bib48","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/01.hco.0000221575.33501.58","article-title":"Lamin A\/C and cardiac diseases","volume":"21","author":"Sylvius","year":"2006","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.ncl.2013.04.004_bib49","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1086\/342975","article-title":"Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome","volume":"71","author":"Beltr\u00e1n-Valero de Bernab\u00e9","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ncl.2013.04.004_bib50","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/jmg.2005.031963","article-title":"POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome","volume":"42","author":"van Reeuwijk","year":"2005","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.ncl.2013.04.004_bib51","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00439-007-0362-y","article-title":"Intragenic deletion in the LARGE gene causes Walker-Warburg syndrome","volume":"121","author":"van Reeuwijk","year":"2007","journal-title":"Hum Genet"},{"key":"10.1016\/j.ncl.2013.04.004_bib52","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/jmg.40.11.845","article-title":"A\u00a0homozygous nonsense mutation in the fukutin gene causes a Walker-Warburg syndrome phenotype","volume":"40","author":"de Bernab\u00e9","year":"2003","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.ncl.2013.04.004_bib53","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1136\/jmg.2003.013870","article-title":"Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome","volume":"41","author":"Beltran-Valero de Bernab\u00e9","year":"2004","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.ncl.2013.04.004_bib54","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/ng.2252","article-title":"ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome","volume":"44","author":"Willer","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.ncl.2013.04.004_bib55","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/ng.2253","article-title":"Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of \u03b1-dystroglycan","volume":"44","author":"Roscioli","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.ncl.2013.04.004_bib56","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ajhg.2012.07.009","article-title":"Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of Walker\u2013Warburg syndrome","volume":"91","author":"Manzini","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ncl.2013.04.004_bib57","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/hmg\/ddt021","article-title":"Missense mutations in \u03b2-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker-Warburg syndrome","volume":"22","author":"Buysse","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ncl.2013.04.004_bib58","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ajhg.2013.01.016","article-title":"Mutations in b3galnt2 cause congenital muscular dystrophy and hypoglycosylation of \u03b1-dystroglycan","volume":"92","author":"Stevens","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ncl.2013.04.004_bib59","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S1534-5807(01)00070-3","article-title":"Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1","volume":"1","author":"Yoshida","year":"2001","journal-title":"Dev Cell"},{"key":"10.1016\/j.ncl.2013.04.004_bib60","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/28256","article-title":"An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy","volume":"394","author":"Kobayashi","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ncl.2013.04.004_bib61","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/hmg\/ddg043","article-title":"Worldwide distribution and broader clinical spectrum of muscle\u2013eye\u2013brain disease","volume":"12","author":"Taniguchi","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ncl.2013.04.004_bib62","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11910-010-0092-8","article-title":"Congenital muscular dystrophies: toward molecular therapeutic interventions","volume":"10","author":"Collins","year":"2010","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.ncl.2013.04.004_bib63","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/archneur.61.5.690","article-title":"Extreme variability of phenotype in patients with an identical missense mutation in the lamin A\/C gene: from congenital onset with severe phenotype to milder classic Emery-Dreifuss variant","volume":"61","author":"Mercuri","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2013.04.004_bib64","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.nmd.2009.01.008","article-title":"ETFDH mutations, CoQ10 levels, and respiratory chain activities in patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency","volume":"19","author":"Liang","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ncl.2013.04.004_bib65","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/jnnp.2009.176404","article-title":"Riboflavin-responsive lipid-storage myopathy caused by ETFDH gene mutations","volume":"81","author":"Wen","year":"2010","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2013.04.004_bib66","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jocn.2003.11.019","article-title":"Primary carnitine deficiency: adult onset lipid storage myopathy with a mild clinical course","volume":"11","author":"Vielhaber","year":"2004","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.ncl.2013.04.004_bib67","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/brain\/109.6.1087","article-title":"The second wind phenomenon in McArdle's disease","volume":"109","author":"Braakhekke","year":"1986","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2013.04.004_bib68","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2013.04.004_bib69","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A\u00a0randomized study of alglucosidase alfa in late-onset pompe\u2019s disease","volume":"362","author":"van der Ploeg","year":"2010","journal-title":"N\u00a0Engl J Med"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861913000431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861913000431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T09:56:50Z","timestamp":1539251810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861913000431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0733861913000431"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2013.04.004","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}